Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum Biomarker Analysis in Pediatric ADHD: Implications of Homocysteine, Vitamin B12, Vitamin D, Ferritin, and Iron Levels.

Children (Basel, Switzerland)·2024
Same author

Serum levels of glucose, thyroid stimulating hormone, and free thyroxine in boys diagnosed with attention deficit hyperactivity disorder: a cross-sectional pilot study.

BMC neurology·2024
Same author

European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke.

European stroke journal·2024
Same author

Cerebral small vessel disease and heart rate variability: A quest for nontraditional risk factors.

Journal of clinical hypertension (Greenwich, Conn.)·2021
Same author

Altered organization of collagen fibers in the uninvolved human colon mucosa 10 cm and 20 cm away from the malignant tumor.

Scientific reports·2020
Same author

Increased risk of cognitive impairment and more severe brain lesions in hypertensive compared to non-hypertensive patients with cerebral small vessel disease.

Journal of clinical hypertension (Greenwich, Conn.)·2018
Same journal

Postponed diagnosis of alpha-1 antitrypsin deficiency.

Srpski arhiv za celokupno lekarstvo·2018
Same journal

Development of cardiopulmonary bypass – A historical review.

Srpski arhiv za celokupno lekarstvo·2018
Same journal

Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.

Srpski arhiv za celokupno lekarstvo·2018
Same journal

Hepatocellular carcinoma and impact of aflatoxin difuranocoumarin derivative system – A case report.

Srpski arhiv za celokupno lekarstvo·2018
Same journal

Mucormycosis of the paranasal sinuses in a patient with acute myeloid leukemia.

Srpski arhiv za celokupno lekarstvo·2018
Same journal

Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis.

Srpski arhiv za celokupno lekarstvo·2018
See all related articles

Related Experiment Video

Updated: Jun 20, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

[Mild cognitive impairment].

Dragan M Pavlović, Aleksandra M Pavlović

    Srpski Arhiv Za Celokupno Lekarstvo
    |September 22, 2009
    PubMed
    Summary
    This summary is machine-generated.

    Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia. While no cure exists, identifying causes and managing risk factors may help slow progression.

    More Related Videos

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
    06:23

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

    Published on: October 13, 2016

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
    07:42

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

    Published on: December 16, 2022

    Related Experiment Videos

    Last Updated: Jun 20, 2026

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
    06:23

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

    Published on: October 13, 2016

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
    07:42

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

    Published on: December 16, 2022

    Area of Science:

    • Neurology
    • Gerontology
    • Psychiatry

    Context:

    • Mild cognitive impairment (MCI) represents a spectrum between normal aging and dementia.
    • MCI classification includes amnestic/non-amnestic and single/multiple domains.
    • Prevalence varies significantly based on diagnostic criteria and population demographics.

    Purpose:

    • To define MCI, its classifications, and prevalence.
    • To outline the range of cognitive and psychological symptoms associated with MCI.
    • To explore the diverse etiologies and prognostic trajectories of MCI.

    Summary:

    • MCI involves cognitive decline less severe than dementia, preserving daily functioning.
    • Etiologies are multifactorial, including neurodegenerative, vascular, and psychiatric causes.
    • Prognosis varies, with some individuals progressing to dementia (e.g., Alzheimer's, frontotemporal dementia), while others stabilize or improve.

    Impact:

    • Highlights the importance of thorough clinical evaluation for MCI diagnosis and management.
    • Underscores the current lack of specific therapies for MCI-related cognitive decline.
    • Emphasizes the role of treating underlying causes, prevention, and risk factor control in managing MCI.